Robert Prins

20PUBLICATIONS
98CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomaterialsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 20, 2026
Armored chimeric antigen receptor T-cell therapy targets antigen-heterogeneous glioma.

|May 13, 2026
Predictable clonal hierarchies from restricted progenitors provide a framework for cell type-specific therapies in glioblastoma.

|Jul 16, 2025
A Human Tumor-Immune Organoid Model of Glioblastoma.

Shivani Baisiwala, Elisa Fazzari, Matthew X Li

|Apr 30, 2025
The T-cell receptor repertoire: A window into pediatric brain tumor immunity.

Takahide Nejo, Robert M Prins, Hideho Okada

|Dec 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort.

J Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef

|Jul 10, 2024
IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma.

Andrew J Hou, Ryan M Shih, Benjamin R Uy

Pageof 4

Frequent Collaborators

9 joint publications

Timothy F Cloughesy

9 joint publications

Richard G Everson

7 joint publications

Linda M Liau

5 joint publications

Alexander Lee